Literature DB >> 23281741

Cancer risk in HFE C282Y homozygotes: results from the HUNT 2 study.

Arne Asberg1, Ketil Thorstensen, Wenche Ø Irgens, Pål R Romundstad, Kristian Hveem.   

Abstract

OBJECTIVE: In addition to hepatocellular cancer, HFE C282Y homozygotes are reported to have increased risk of colorectal cancer and breast cancer. This study was done to further explore the cancer risk in C282Y homozygotes.
MATERIAL AND METHODS: We studied cancer incidence in 292 homozygotes and 62,568 others that participated in the HUNT 2 population screening in 1995-1997. Using Cox proportional hazard models, we estimated cancer hazard ratio as a function of C282Y homozygosity and several screening variables including serum transferrin saturation, alcohol consumption and daily smoking.
RESULTS: Cancer was diagnosed in 36 homozygotes, five of which had two cancer diagnoses. The overall cancer incidence was not increased in C282Y homozygotes (hazard ratio 1.10 [95% CI 0.60-2.03] in women and 0.94 [95% CI 0.53-1.66] in men). However, homozygous men had increased risk of colorectal cancer (hazard ratio 3.03 [95% CI 1.17-7.82], p = 0.022) and primary liver cancer (hazard ratio 54.0 [95% CI 2.68-1089], p = 0.009). The risk of breast cancer in homozygous women was not increased (hazard ratio 1.13 [95% CI 0.35-3.72]). Adjusted for other variables including C282Y homozygosity, very low and very high serum transferrin saturation were associated with increased overall cancer incidence.
CONCLUSIONS: C282Y homozygosity is associated with increased risk of colorectal cancer and hepatocellular cancer in men. In the general population, individuals with a very low or a very high serum transferrin saturation may have increased cancer risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281741     DOI: 10.3109/00365521.2012.752028

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.

Authors:  Weidong Chen; Hua Zhao; Tiegang Li; Hongliang Yao
Journal:  Tumour Biol       Date:  2013-04-04

2.  C282Y polymorphism in the HFE gene is associated with risk of breast cancer.

Authors:  Xiaoyan Liu; Chunlei Lv; Xiaorong Luan; Ming Lv
Journal:  Tumour Biol       Date:  2013-05-17

3.  Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Authors:  Rebecca E Graff; Eunyoung Cho; Sara Lindström; Peter Kraft; Walter C Willett; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-17       Impact factor: 4.254

4.  Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.

Authors:  Agustin Castiella; Fernando Múgica; Eva Zapata; Leire Zubiaurre; Arantxa Iribarren; M Dolores de Juan; Luis Alzate; Ines Gil; Gregorio Urdapilleta; Pedro Otazua; José Ignacio Emparanza
Journal:  Tumour Biol       Date:  2015-04-09

Review 5.  Evidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical Populations.

Authors:  Cody Weston; James Connor
Journal:  Transl Oncogenomics       Date:  2014-12-04

6.  The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.

Authors:  Yang-Fan Lv; Xian Chang; Rui-Xi Hua; Guang-Ning Yan; Gang Meng; Xiao-Yu Liao; Xi Zhang; Qiao-Nan Guo
Journal:  J Cell Mol Med       Date:  2016-02-19       Impact factor: 5.310

7.  Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data.

Authors:  Sang Y Lee; Junjia Zhu; Anna C Salzberg; Bo Zhang; Dajiang J Liu; Joshua E Muscat; Sara T Langan; James R Connor
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

Review 8.  Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.

Authors:  Scott D Grosse; Lyle C Gurrin; Nadine A Bertalli; Katrina J Allen
Journal:  Genet Med       Date:  2017-08-03       Impact factor: 8.822

9.  Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients.

Authors:  Hidenao Noritake; Yoshimasa Kobayashi; Yukimasa Ooba; Kensuke Kitsugi; Shin Shimoyama; Satoru Yamazaki; Takeshi Chida; Shinya Watanabe; Kazuhito Kawata; Takafumi Suda
Journal:  ISRN Hepatol       Date:  2014-02-04

10.  Hereditary hemochromatosis promotes colitis and colon cancer and causes bacterial dysbiosis in mice.

Authors:  Sathish Sivaprakasam; Bojana Ristic; Nithya Mudaliar; Abdul N Hamood; Jane Colmer-Hamood; Mitchell S Wachtel; Anna G Nevels; Kameswara R Kottapalli; Vadivel Ganapathy
Journal:  Biochem J       Date:  2020-10-16       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.